Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical and global medical imaging company, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2014. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 2:30pm PST (5:30pm EST).
Help employers find you! Check out all the jobs and post your resume.
